company

PRONOFA PROTEIN AS

1608 FREDRIKSTAD

Return on Equity
168,63 %
Current Ratio
0,65
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue0
Net Income−172 000
Total Assets225 000
Total Equity−102 000
Income (NOK)2022
Revenue0
Expenditure172 000
Operating Profit−172 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−172 000
Tax0
Net Income−172 000
Balance (NOK)2022
Total Fixed Assets12 000
Total Current Assets213 000
Total Assets225 000
Total Retained Equity−156 000
Total Equity−102 000
Total Long-Term Debt0
Total Current Debt327 000
Total Equity and Debt225 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation5 000
Impairment0
Expenditure172 000
Operating Profit−172 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−172 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures12 000
Total Tangible Assets12 000
Total Fiancial Fixed Assets0
Total Fixed Assets12 000
Stock0
Total Investments0
Cash, Bank213 000
Total Current Assets213 000
Total Assets225 000
Total Equity−102 000
Short-Term Group Debt200 000
Total Long-Term Debt0
Creditors5 000
Unpaid Taxes−1 000
Dividends0
Other Current Debt123 000
Total Current Debt327 000
Total Equity and Debt225 000
Financial indicators2022
Return on Equity168,63 %
Debt-to-Equity Ratio−0
Operating Profit Margin-
Current Ratio0,65
Quick Ratio0,65
Equity Ratio−0,45
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English